Literature DB >> 10547159

Relationship of survival, organism containment, and granuloma formation in acute murine tuberculosis.

J K Actor1, M Olsen, C Jagannath, R L Hunter.   

Abstract

The relationship among organism growth, immunopathology, and survival was studied in C57BL/6 and A/J mice acutely infected with Mycobacterium tuberculosis (MTB) (Erdman). Although organisms grew at similar rates in the lungs of both mouse strains, A/J mice died prior to 14 days after infection, whereas C57BL/6 mice survived twice as long. The lungs of A/J mice exhibited necrotizing interstitial inflammation and widely distributed acid-fast bacilli without granuloma formation. In contrast, the lungs of C57BL/6 mice had relatively mild interstitial inflammation, which was replaced by focal granulomas, and acid-fast bacilli were primarily within granulomas. MTB induced similar granulomas for A/J and C57BL/6 mice in spleen and liver. In the lung, the A/J mice produced only transient messages for interferon-y (IFN-y), interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), IL-10, and inducible nitric oxide synthase (iNOS). The C57BL/6 mice, in contrast, produced a delayed but sustained response in the lung correlating with granuloma onset and characterized by high induction of IL-6, IFN-gamma, IL-1beta, IL-10, and TNF-alpha. Responses in the liver and spleen were also evaluated. These results demonstrate that histopathology and cytokine response to MTB infection varies among organs in mice. Increased survival during acute infection may, therefore, depend on the ability to contain organisms within granulomas in the lung.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547159     DOI: 10.1089/107999099313136

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  14 in total

1.  Mycobacterial glycolipid cord factor trehalose 6,6'-dimycolate causes a decrease in serum cortisol during the granulomatous response.

Authors:  Jeffrey K Actor; Jessica Indrigo; Christopher M Beachdel; Margaret Olsen; Alice Wells; Robert L Hunter; Amitava Dasgupta
Journal:  Neuroimmunomodulation       Date:  2002 -2003       Impact factor: 2.492

2.  Gene expression analysis of mouse chromosome substitution strains.

Authors:  Keith R Shockley; Gary A Churchill
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

3.  Mycobacterium microti tuberculosis in its maintenance host, the field vole (Microtus agrestis): characterization of the disease and possible routes of transmission.

Authors:  A Kipar; S J Burthe; U Hetzel; M Abo Rokia; S Telfer; X Lambin; R J Birtles; M Begon; M Bennett
Journal:  Vet Pathol       Date:  2013-12-13       Impact factor: 2.221

4.  Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes.

Authors:  Shen-An Hwang; Katarzyna M Wilk; Yogesh A Bangale; Marian L Kruzel; Jeffrey K Actor
Journal:  Med Microbiol Immunol       Date:  2007-03-22       Impact factor: 3.402

5.  IL-6 mediates 11βHSD type 2 to effect progression of the mycobacterial cord factor trehalose 6,6'-dimycolate-induced granulomatous response.

Authors:  April N Abbott; Kerry J Welsh; Shen-An Hwang; Paulina Płoszaj; Tina Choudhury; Sydney Boyd; Michael R Blackburn; Robert L Hunter; Jeffrey K Actor
Journal:  Neuroimmunomodulation       Date:  2011-03-08       Impact factor: 2.492

6.  Joint effects of host genetic background and mycobacterial pathogen on susceptibility to infection.

Authors:  Tania Di Pietrantonio; José A Correa; Marianna Orlova; Marcel A Behr; Erwin Schurr
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

7.  A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential.

Authors:  Robert H Copenhaver; Eliud Sepulveda; Lisa Y Armitige; Jeffrey K Actor; Audrey Wanger; Steven J Norris; Robert L Hunter; Chinnaswamy Jagannath
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 8.  Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials.

Authors:  Alexandra V Yamshchikov; Nirali S Desai; Henry M Blumberg; Thomas R Ziegler; Vin Tangpricha
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

9.  Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis.

Authors:  Shen-An Hwang; Katarzyna M Wilk; Monika Budnicka; Margaret Olsen; Yogesh A Bangale; Robert L Hunter; Marian L Kruzel; Jeffrey K Actor
Journal:  Vaccine       Date:  2007-07-27       Impact factor: 3.641

Review 10.  Animal welfare in studies on murine tuberculosis: assessing progress over a 12-year period and the need for further improvement.

Authors:  Nuno Henrique Franco; Margarida Correia-Neves; I Anna S Olsson
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.